During the past decade, MS Center of Greater Washington conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MS Center of Greater Washington" #1 sponsor was "Anokion SA" with 1 trials, followed by "Atara Biotherapeutics" with 1 trials sponsored, "Avanir Pharmaceuticals" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MS Center of Greater Washington" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Genzyme, a Sanofi Company" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MS Center of Greater Washington" are "Multiple Sclerosis" (2 trials), "Relapsing Remitting Multiple Sclerosis" (2 trials), "Central Neuropathic Pain" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "MS Center of Greater Washington" in a lesser frequency.

Most popular intervention types in "MS Center of Greater Washington" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ANK-700" (1 trials), "ATA188" (1 trials), "AVP-923-20" (1 trials) and "AVP-923-30" (1 trials). Other intervention names were less common.

The vast majority of trials in "MS Center of Greater Washington" are 7 trials for "All" genders.

Currently, there are NaN active trials in "MS Center of Greater Washington". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MS Center of Greater Washington, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MS Center of Greater Washington, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".